Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP251121.RALKZv_eYlQ__rlH6iS6VUdpJVVx-urh8oJTT1uOTG6Ds130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP251121.RALKZv_eYlQ__rlH6iS6VUdpJVVx-urh8oJTT1uOTG6Ds130_assertion type Assertion NP251121.RALKZv_eYlQ__rlH6iS6VUdpJVVx-urh8oJTT1uOTG6Ds130_head.
- NP251121.RALKZv_eYlQ__rlH6iS6VUdpJVVx-urh8oJTT1uOTG6Ds130_assertion description "[In most cases of CML and some cases of Ph+ ALL the protooncogene ABL from 9q34 is translocated to the breakpoint cluster region (bcr) of the BCR gene at 22q11 to form a chimeric gene encoding a novel 210-kd protein (P210 BCR-ABL) with enhanced tyrosine kinase activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP251121.RALKZv_eYlQ__rlH6iS6VUdpJVVx-urh8oJTT1uOTG6Ds130_provenance.
- NP251121.RALKZv_eYlQ__rlH6iS6VUdpJVVx-urh8oJTT1uOTG6Ds130_assertion evidence source_evidence_literature NP251121.RALKZv_eYlQ__rlH6iS6VUdpJVVx-urh8oJTT1uOTG6Ds130_provenance.
- NP251121.RALKZv_eYlQ__rlH6iS6VUdpJVVx-urh8oJTT1uOTG6Ds130_assertion SIO_000772 3179449 NP251121.RALKZv_eYlQ__rlH6iS6VUdpJVVx-urh8oJTT1uOTG6Ds130_provenance.
- NP251121.RALKZv_eYlQ__rlH6iS6VUdpJVVx-urh8oJTT1uOTG6Ds130_assertion wasDerivedFrom befree-20150227 NP251121.RALKZv_eYlQ__rlH6iS6VUdpJVVx-urh8oJTT1uOTG6Ds130_provenance.
- NP251121.RALKZv_eYlQ__rlH6iS6VUdpJVVx-urh8oJTT1uOTG6Ds130_assertion wasGeneratedBy ECO_0000203 NP251121.RALKZv_eYlQ__rlH6iS6VUdpJVVx-urh8oJTT1uOTG6Ds130_provenance.